Peloton Interactive Inc vs Twist Bioscience Corp — how do they compare? Peloton Interactive Inc trades at $6.28 (market cap $2.75B), while Twist Bioscience Corp trades at $93.82 (market cap $5.97B). The key difference: Twist Bioscience Corp is far larger — about 2.2× Peloton Interactive Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Peloton Interactive Inc nearer its low. Which is the better fit depends on your goals.
| PTON | TWST | |
|---|---|---|
Market Cap | $2.75B | $5.97B |
Sector | Consumer Cyclical | Health |
52-Week High | $9.00 | $102.88 |
52-Week Low | $3.71 | $24.16 |
Enterprise Value | $3.35B | $5.89B |
Signals from Pluang's Aura AI — not financial advice
Peloton (PTON) trades at $6.36, up 3.92% on the day, showing improved technical momentum with bullish moving average signals. The company demonstrates significant operational turnaround with positive operating cash flow of $333M in 2025 and projected net profitability in 2026. Recent earnings show mixed results with Q3 2025 beating expectations but subsequent quarters missing. The stock faces challenges from declining revenue trends and negative shareholder equity of -$519.2M, though cost-cutting measures and new leadership appointments provide potential catalysts.
The outlook remains cautiously optimistic with analyst consensus pointing to 18% upside to the $7.50 price target. Key opportunities include continued cash flow improvement and potential market share stabilization, while risks center on persistent revenue declines and high debt levels. The company's inclusion in the S&P SmallCap 600 index provides additional institutional visibility, though execution on growth initiatives remains critical for sustained recovery.
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
Trailing returns across standard periods
Latest headlines on both assets
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →